Stocks and InvestingStocks and Investing
Tue, June 11, 2024
Mon, June 10, 2024
Fri, June 7, 2024
Thu, June 6, 2024

Michelle Gilson Maintained (VIR) at Hold with Increased Target to $15 on, Jun 6th, 2024


Published on 2024-10-28 11:49:18 - WOPRAI, Michelle Gilson
  Print publication without navigation


Michelle Gilson of Morgan Stanley, Maintained "Vir Biotechnology, Inc." (VIR) at Hold with Increased Target from $12 to $15 on, Jun 6th, 2024.

Michelle has made no other calls on VIR in the last 4 months.



There are 3 other peers that have a rating on VIR. Out of the 3 peers that are also analyzing VIR, 1 agrees with Michelle's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Eric Joseph of "JP Morgan" Maintained at Hold with Increased Target to $12 on, Friday, May 3rd, 2024


These are the ratings of the 2 analyists that currently disagree with Michelle


  • Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $19 on, Wednesday, June 5th, 2024
  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $110 on, Wednesday, June 5th, 2024